These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 5983049)

  • 1. Studies on X-agent. XLIX. A great change observed during 1965 in the action of X-agent on colloidal solutions of bismuth-oxychloride.
    Moriyama H
    Yokohama Med Bull; 1966 Aug; 17(4):107-13. PubMed ID: 5983049
    [No Abstract]   [Full Text] [Related]  

  • 2. STUDIES ON X-AGENT. XLII. SOFT X-AGENT CAPABLE OF AFFECTING THE CLOUDINESS OF COLLOIDAL SOLUTIONS OF BISMUTH-OXYCHLORIDE.
    MORIYAMA H
    Yokohama Med Bull; 1965 Feb; 16():9-16. PubMed ID: 14326362
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on X-agent.48. Fluctuation of harder components of X-agent capable of affecting alkaline-aqueous solutions of neutral red.
    Moriyama H
    Yokohama Med Bull; 1966 Jun; 17(3):67-73. PubMed ID: 5962262
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on X-agent. LI. Effects of X-agent on alkaline thymol-blue solutions.
    Moriyama H
    Yokohama Med Bull; 1966 Dec; 17(6):201-8. PubMed ID: 5983542
    [No Abstract]   [Full Text] [Related]  

  • 5. [Physical changes in a bismuth oxychloride suspension induced by exogenous influence (author's transl)].
    Herrmann R; Pichl H; Henneberg G
    Zentralbl Bakteriol Orig A; 1974 Jun; 226(4):510-23. PubMed ID: 4152706
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on X-agent. LIV. The light-effect on the direction-pattern formed by X-agent in pigment solutions arranged around a bottle of water with special reference to the great change observed with X-agent about 1965.
    Moriyama H
    Yokohama Med Bull; 1967 Jun; 18(3):73-84. PubMed ID: 6061911
    [No Abstract]   [Full Text] [Related]  

  • 7. Bismuth telluride functionalized bismuth oxychloride used for enhancing antibacterial activity and wound healing efficacy with sunlight irradiation.
    Chen R; Wei L; Yan Y; Chen G; Yang X; Liu Y; Zhang M; Liu X; Cheng Y; Sun J; Wang L
    Biomater Sci; 2022 Jan; 10(2):467-473. PubMed ID: 34889922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological properties of colloidal bismuth subcitrate (CBS, DE-NOL).
    Wieriks J; Hespe W; Jaitly KD; Koekkoek PH; Lavy U
    Scand J Gastroenterol Suppl; 1982; 80():11-6. PubMed ID: 6962539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STUDIES ON X-AGENT. XXXIII. FURTHER STUDIES ON TIME-FLUCTUATION OF X-AGENT.
    MORIYAMA H
    Yokohama Med Bull; 1963 Dec; 14():269-86. PubMed ID: 14163389
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on X-agent. LVI. Influence of heat radiation upon X-agent in promoting its action.
    Moriyama H
    Yokohama Med Bull; 1967 Dec; 18(6):235-44. PubMed ID: 5591997
    [No Abstract]   [Full Text] [Related]  

  • 11. STUDIES ON X-AGENT. XXXII. SHIELDING EFFECTS OF METALLIC AND NON-METALLIC SUBSTANCES, AND ALSO INFLUENCES OF WATER, ON X-AGENT WITH RESPECT TO THE ACTION OF THE AGENT ON THE CLOUDINESS OF BISMUTH-OXYCHLORIDE SUSPENSION.
    MORIYAMA H
    Yokohama Med Bull; 1963 Oct; 14():235-52. PubMed ID: 14088621
    [No Abstract]   [Full Text] [Related]  

  • 12. Interaction between proteins and salt solutions. 3. Effect of salt type and concentration on the shrinkage temperature.
    Ciferri A; Rajagh LV; Puett D
    Biopolymers; 1965; 3(4):461-80. PubMed ID: 5889559
    [No Abstract]   [Full Text] [Related]  

  • 13. Female breast radiation exposure during thorax multidetector computed tomography and the effectiveness of bismuth breast shield to reduce breast radiation dose.
    Yilmaz MH; Albayram S; Yaşar D; Ozer H; Adaletli I; Selçuk D; Akman C; Altuğ A
    J Comput Assist Tomogr; 2007; 31(1):138-42. PubMed ID: 17259846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of lead in urine by atomic absorption spectroscopy using coprecipitation with bismuth.
    Kopito L; Shwachman H
    J Lab Clin Med; 1967 Aug; 70(2):326-32. PubMed ID: 6029061
    [No Abstract]   [Full Text] [Related]  

  • 15. Thiosulphate compleximetric determination of bismuth in some organic pharmaceutical chemicals.
    Amer MM; Stáhlawská A; Kader SA; Tawakkol MS
    Pharmazie; 1974 Jun; 29(6):418-9. PubMed ID: 4212467
    [No Abstract]   [Full Text] [Related]  

  • 16. Epitaxial growth of silver chloride crystals on bismuth oxychloride.
    Bokhonov BB
    Dalton Trans; 2015 Jan; 44(1):176-81. PubMed ID: 25363604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A potential mechanism of action of colloidal bismuth subcitrate: diffusion barrier to hydrochloric acid.
    Lee SP
    Scand J Gastroenterol Suppl; 1982; 80():17-21. PubMed ID: 6962540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on X-agent. L. Further studies on diurnal fluctuation of X-agent revealed in its action on the apparent transparency of frosted glass surfaces.
    Moriyama H
    Yokohama Med Bull; 1966 Oct; 17(5):157-64. PubMed ID: 5974645
    [No Abstract]   [Full Text] [Related]  

  • 19. [Some physico-chemical properties of bismuth salts used in pharmacy].
    Billon JP; Gernez G; Gourdin JC; Martin C; Palliere M
    Ann Pharm Fr; 1976; 34(5-6):161-71. PubMed ID: 999151
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis and structures of the first bismuth-ester complexes using heterobifunctional thiolate anchored ligands and mass spectrometric identification of ligand-bridged derivatives.
    Briand GG; Burford N; Eelman MD; Cameron TS; Robertson KN
    Inorg Chem; 2003 May; 42(9):3136-41. PubMed ID: 12716213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.